Related Experiment Videos
Transplantation of islet cells
Surgery, Gynecology & Obstetrics
|January 1, 1984
Summary
Cyclosporine A (Cy A) pretreatment and immunosuppression improved canine pancreatic islet cell allograft viability after cryopreservation. This technique shows promise for future transplantation applications.
Area of Science:
- Transplantation immunology
- Cryobiology
- Endocrinology
Background:
- Pancreatic islet cell transplantation is a potential therapy for diabetes.
- Cryopreservation of islet grafts can compromise their viability and function.
- Effective immunosuppression is crucial for allograft survival.
Purpose of the Study:
- To assess the efficacy of Cyclosporine A (Cy A) in improving canine pancreatic islet allograft viability after cryopreservation.
- To evaluate the long-term function of cryopreserved islet allografts with Cy A pretreatment and immunosuppression.
Main Methods:
- Canine pancreatic islet cells were cryopreserved at -196°C.
- Grafts underwent pretreatment with Cy A.
- Recipients received Cy A as a general immunosuppressant post-pancreatectomy.
Main Results:
- Cryopreserved islet cell allografts demonstrated good viability.
- Long-term function of the allografts was successfully maintained.
- The combination therapy proved effective in preserving graft integrity.
Conclusions:
- Cyclosporine A pretreatment and immunosuppression enhance the viability of cryopreserved canine pancreatic islet allografts.
- This approach offers a promising strategy for improving islet transplantation outcomes.
- Further research into this technique could advance clinical islet transplantation.